342 related articles for article (PubMed ID: 9464430)
1. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions.
Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT
Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430
[TBL] [Abstract][Full Text] [Related]
2. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
4. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
6. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions.
Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H
Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790
[TBL] [Abstract][Full Text] [Related]
7. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
8. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy.
Cwikla JB; Buscombe JR; Kelleher SM; Parbhoo SP; Thakrar DS; Hinton J; Deery AR; Crow J; Hilson AJ
Clin Radiol; 1998 Apr; 53(4):274-80. PubMed ID: 9585043
[TBL] [Abstract][Full Text] [Related]
9. (99M)Technetium-sestamibi scintimammography in non-palpable breast lesions found on screening X-ray mammography.
Gommans GM; van der Zant FM; van Dongen A; Boer RO; Teule GJ; de Waard JW
Eur J Surg Oncol; 2007 Feb; 33(1):23-7. PubMed ID: 17126524
[TBL] [Abstract][Full Text] [Related]
10. Role of technetium tetrofosmin scintimammography in the diagnosis of malignant breast masses and axillary lymph node involvement: a comparative study with mammography and histopathology.
Ortapamuk H; Ozmen MM; Ibis S; Naldöken S; Aksoy F
Eur J Surg; 1999 Dec; 165(12):1147-53. PubMed ID: 10636548
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of technetium-99m tetrofosmin scintimammography to detect breast cancer in mammographically dense breasts.
Yang MD; Sun SS; Kao CH; Lin CC; Lee CC
Cancer Invest; 2002; 20(4):518-23. PubMed ID: 12094547
[TBL] [Abstract][Full Text] [Related]
12. Positive predictive value of 99mTc sestamibi scintimammography in patients with non-palpable, mammographically detected, suspicious, breast lesions.
Lumachi F; Zucchetta P; Marzola MC; Ferretti G; Povolato M; Paris MK; Brandes AA; Bui F
Nucl Med Commun; 2002 Nov; 23(11):1073-8. PubMed ID: 12411835
[TBL] [Abstract][Full Text] [Related]
13. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
14. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
[TBL] [Abstract][Full Text] [Related]
15. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Lee JK; Kao CH
Anticancer Res; 2000; 20(3B):2133-6. PubMed ID: 10928166
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI.
Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D
Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644
[TBL] [Abstract][Full Text] [Related]
17. Complementary use of scintimammography with 99m-Tc-MIBI to triple diagnostic procedure in palpable and non-palpable breast lesions.
Wilczek B; Aspelin P; Boné B; Pegerfalk A; Frisell J; Danielsson R
Acta Radiol; 2003 May; 44(3):288-93. PubMed ID: 12752000
[TBL] [Abstract][Full Text] [Related]
18. 99Tc(m)-tetrofosmin scintimammography for detecting breast cancer: a comparative study with 99Tc(m)-MIBI.
Horne T; Pappo I; Cohen-Pour M; Baumer M; Orda R
Nucl Med Commun; 2001 Jul; 22(7):807-11. PubMed ID: 11453054
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of scintimammography as an additional test to conventional mammography in detection of breast cancer].
Cwikła JB; Buscombe JR; Kolasińska AD; Holloway B; Hilson AJ
Ginekol Pol; 2003 May; 74(5):362-70. PubMed ID: 12931463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
